SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-06-034293
Filing Date
2006-05-12
Accepted
2006-05-12 14:31:53
Documents
7
Period of Report
2006-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a06-9916_110q.htm 10-Q 656275
2 EX-31 a06-9916_1ex31d1.htm EX-31.1 12798
3 EX-31 a06-9916_1ex31d2.htm EX-31.2 13507
4 EX-32 a06-9916_1ex32d1.htm EX-32.1 5617
5 EX-32 a06-9916_1ex32d2.htm EX-32.2 5583
6 GRAPHIC g99161bai001.jpg GRAPHIC 6306
7 GRAPHIC g99161bai002.jpg GRAPHIC 877
  Complete submission text file 0001104659-06-034293.txt   705442
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 06834036
SIC: 2834 Pharmaceutical Preparations